SCH-442416 : Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
cytarabine :Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease
AZD1152-HQPA : Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt’s and Hodgkin’s lymphomas
VX-680 :An investigation into the prediction of the plasma concentration-time profile and its inter-individual variability for a range of flavin-containing monooxygenase substrates using a physiologically based pharmacokinetic modelling approach
RK 24466 : Novel dual Src/Abl inhibitors for hematologic and solid malignancies